Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-16 · accession 0000950170-25-075191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-20 | 2025-05-20 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +540.0K | 1.69M | +47% | $0 | |
| 2025-05-20 | 2025-05-16 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $0.58 | -13.4K | 1.15M | -1% | -$7,745 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-20 | A | A | 540,000 | $0.00 | 1,687,281 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-05-16 | S | D | 13,353 | $0.58 | 1,147,281 | D | — | — |